|
FAM122B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.745800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.747200E-01 |
| Normal-vs-Stage2 |
4.892200E-01 |
| Normal-vs-Stage3 |
5.596400E-01 |
| Normal-vs-Stage4 |
7.392200E-02 |
| Stage1-vs-Stage2 |
4.021600E-01 |
| Stage1-vs-Stage3 |
8.706400E-01 |
| Stage1-vs-Stage4 |
9.092000E-02 |
| Stage2-vs-Stage3 |
3.813000E-01 |
| Stage2-vs-Stage4 |
1.883360E-01 |
| Stage3-vs-Stage4 |
2.438200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.102800E-01 |
| Normal-vs-AfricanAmerican |
6.736400E-01 |
| Normal-vs-Asian |
4.470000E-01 |
| Caucasian-vs-AfricanAmerican |
5.079400E-01 |
| Caucasian-vs-Asian |
2.301400E-01 |
| AfricanAmerican-vs-Asian |
5.986800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.401200E-01 |
| Normal-vs-Female |
1.183000E-01 |
| Male-vs-Female |
2.439800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.010200E-01 |
| Normal-vs-Extreme_Weight |
5.173600E-01 |
| Normal-vs-Obese |
6.744800E-01 |
| Normal-vs-Extreme_Obese |
1.937360E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.733800E-01 |
| Normal_Weight-vs-Obese |
5.706200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.654600E-01 |
| Extreme_Weight-vs-Obese |
3.920600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.827000E-01 |
| Obese-vs-Extreme_Obese |
1.886430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.097200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.044800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.132200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.287000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.670800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.541790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.669900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.769040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.617800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.416000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.111800E-01 |
| Normal-VS-Type2 PRCC |
5.281200E-03 |
| Normal-VS-KIRP CIMP |
5.958000E-01 |
| Normal-VS-Unclassified PRCC |
7.196000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.08990000000387E-05 |
| Type1 PRCC-VS-KIRP CIMP |
9.992200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.367400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.324100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.395300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.906800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.454800E-01 |
| Normal-vs-N1 |
9.806600E-01 |
| Normal-vs-N2 |
6.070600E-01 |
| N0-vs-N1 |
3.920000E-01 |
| N0-vs-N2 |
9.306800E-01 |
| N1-vs-N2 |
7.720000E-01 |
|
|
